Platelet aggregation inhibitor prescription for newly diagnosed peripheral arterial disease in the Netherlands: a cohort study

OBJECTIVES: Pharmacological treatment of peripheral arterial disease (PAD) comprises of antiplatelet therapy (APT), blood pressure control and cholesterol optimisation. Guidelines provide class-I recommendations on the prescription, but there are little data on the actual prescription practices. Our...

Descripción completa

Detalles Bibliográficos
Autores principales: Brand, Aarent RT, Houben, Eline, Bezemer, Irene D, Visseren, Frank L J, Bots, Michiel L, Herings, Ron MC, de Borst, Gert J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818814/
https://www.ncbi.nlm.nih.gov/pubmed/33472782
http://dx.doi.org/10.1136/bmjopen-2020-041715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818814/
https://www.ncbi.nlm.nih.gov/pubmed/33472782
http://dx.doi.org/10.1136/bmjopen-2020-041715

Ejemplares similares